Autoimmune hepatitis (AIH) is a chronic liver disease of unknown aetiology and characterized by continuing hepatocellular inflammation and necrosis. Autoantibodies represent accessible markers to measure the adaptive immune responses in the clinical investigation. Protein microarrays have become an important tool to discriminate the disease state from control groups, even though there is no agreed-upon standard to analyze the results.
Two of Them Do It Better : Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis / S. Mazzara, A. Sinisi, A. Cardaci, R.L. Rossi, L. Muratori, S. Abrignani, M. Bombaci. - In: PLOS ONE. - ISSN 1932-6203. - 10:9(2015 Sep 16), pp. e0137927.1-e0137927.20.
Two of Them Do It Better : Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis
S. AbrignaniPenultimo
;
2015
Abstract
Autoimmune hepatitis (AIH) is a chronic liver disease of unknown aetiology and characterized by continuing hepatocellular inflammation and necrosis. Autoantibodies represent accessible markers to measure the adaptive immune responses in the clinical investigation. Protein microarrays have become an important tool to discriminate the disease state from control groups, even though there is no agreed-upon standard to analyze the results.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Two of Them Do It Better Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis..pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
5.91 MB
Formato
Adobe PDF
|
5.91 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
